Peptide-Based Inhibitors of Fimbrial Biogenesis in Porphyromonas gingivalis-Reference-Cited by-同舟云学术

Peptide-Based Inhibitors of Fimbrial Biogenesis in Porphyromonas gingivalis

Published:2019-03 Issue:3 Volume:87 Page:
ISSN:0019-9567
Container-title:Infection and Immunity
language:en
Short-container-title:Infect Immun

Author:

Alaei Sarah R.¹²,Park Jin Ho¹²,Walker Stephen G.³,Thanassi David G.¹²

Affiliation:

1. Department of Molecular Genetics and Microbiology, School of Medicine, Stony Brook University, Stony Brook, New York, USA

2. Center for Infectious Diseases, Stony Brook University, Stony Brook, New York, USA

3. Department of Oral Biology and Pathology, School of Dental Medicine, Stony Brook University, Stony Brook, New York, USA

Abstract

Periodontitis is a progressive inflammatory disease that affects roughly half of American adults. Colonization of the oral cavity by the Gram-negative bacterial pathogen Porphyromonas gingivalis is a key event in the initiation and development of periodontal disease.

Funder

HHS | NIH | National Institute of General Medical Sciences

HHS | NIH | National Heart, Lung, and Blood Institute

Publisher

American Society for Microbiology

Subject

Infectious Diseases,Immunology,Microbiology,Parasitology

Link

https://journals.asm.org/doi/pdf/10.1128/IAI.00750-18

Reference68 articles.

1. Years lived with disability (YLDs) for 1160 sequelae of 289 diseases and injuries 1990–2010: a systematic analysis for the Global Burden of Disease Study 2010

2. Periodontitis: from microbial immune subversion to systemic inflammation